Thalidomide promotes transplanted cell engraftment in the rat liver by modulating inflammation and endothelial integrity
The trial did not resume enrollment Preclinical cardiac evidence: Animal models of myocardial infarction demonstrated RGN-352 reduced scar volume, improved cardiac function, and increased survival, forming the basis for the clinical program (PMID: 25015963) RGN-259 (Thymosin Beta-4 Ophthalmic Solution for Dry Eye): ARISE-1 and ARISE-2 Phase 3 trials: Evaluated Thymosin Beta-4 eye drops for dry eye disease with mixed results some endpoints showed improvement in signs of dry eye, but the pre-specified co-primary endpoints were not met, though some secondary endpoints showed statistically significant improvements in certain signs of dry eye (PMID: 23050815) These ophthalmic trials represent the most advanced clinical testing of any Thymosin Beta-4 formulation Independent Pilot Study (China, 2016): A small pilot study randomized 10 STEMI (heart attack) patients into two groups: 5 receiving Thymosin Beta-4-pretreated endothelial progenitor cells (EPCs) and 5 receiving untreated EPCs After 6 months, the Thymosin Beta-4-pretreated group showed trends toward improved cardiac function markers including ejection fraction and exercise capacity, though the very small sample size (n=5 per group) means these results should be considered hypothesis-generating only, not evidence of efficacy (PMID: 27288307) No severe complications were reported in either group during follow-up Important: This study used Thymosin Beta-4 as a cell pretreatment agent ex vivo (EPCs exposed to TB4 before transplantation), not as a directly administered drug
Batch: GF-BPCTB5-B241 BPC-157 Assay: 7.36 mg BPC-157 Purity: 99.2 percent BPC-157 Identification by RT: 0.995 Molecular Ion Mass Identification (BPC-157): 1418 Da TB-500 Assay: 6.11 mg TB-500 Purity: greater than 99.8 percent TB-500 Identification by RT: 0.996 Molecular Ion Mass Identification (TB-500): 4963 Da Bacterial Endotoxins: below 0.001 EU/mg Total Aerobic Microbial Count: Not detected Total Yeast and Mold Count: Not detected Research Applications In controlled laboratory environments, BPC-157 / TB-500 may be utilised in experimental models designed to investigate peptide signalling systems and molecular interaction pathways
Descripcin Si buscas comprar BPC-157 en Espaa para uso de investigacin, este vial liofilizado de 5 mg ofrece pureza certificada del +99% por HPLC, identidad por LC-MS y certificado de anlisis (COA) independiente por lote
